MM+M is proud to reintroduce you to its 2022 Women of Distinction and Women to Watch honorees.
As Congress struggles to secure more pandemic aid, experts are once again calling for long-term investment in public health infrastructure. Will anyone listen?
Bristol Myers Squibb’s Opdivo/Yervoy combo for bladder cancer fails in Phase III study; Former FDA digital health chief joins Google; Seagan CEO resigns following domestic violence allegations.
The company partnered with Dr. Jen Richardson, a hearing loss advocate and educational audiologist, to make sure its portrayal of real people was accurate.
The disclosure indicated that errors were related to the recognized revenue from a commercialization agreement with Kyowa Kirin Co.
53 of the industry’s most esteemed women leaders and up-and-comers will be honored at this year’s in-person celebration, set for June 7 in New York City.
As the metaverse meteor heads toward online patient and disease communities, many longstanding posters worry it will disturb some of the safest places in cyberspace.
From the opening keynote to the closing one, here are audio snippets from the full MM+M Transform program.
MRM for Health's new global study deconstructs our fraying relationship with health and healthcare.
The next frontier of innovation lies in thoughtfully utilizing patient support programs.
A conversation with CDMP president Craig Romanok on keeping it fresh, fun and meaningful.
In this podcast, Healio’s John C. Carter, chief operating officer and Joan-Marie Stiglich, ELS, chief content officer, discuss the origins and future of Healio.